Bison is made up entirely of investors with engineering backgrounds, and they invest in frontier-tech companies once the core science has been proven but before it has been fully scaled, commercialized, or brought to market—often at the intersection of fields like robotics and biology or AI and drug discovery, and with a preference for robotics companies built for fast, modular deployment rather than moonshot-style projects. The firm has also backed teams where more than 80% of CEOs came from groups traditionally underrepresented in venture-backed startups, including women making up half of that group.